Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges

Current Addiction Reports
Rachel L TomkoErin A McClure

Abstract

Cannabis abstinence traditionally is the primary outcome in cannabis use disorder (CUD) treatment trials. Due to the changing legality of cannabis, patient goals, and preliminary evidence that suggests individuals who reduce their cannabis use may show functional improvements, cannabis reduction is a desirable alternative outcome in CUD trials. We review challenges in measuring cannabis reduction and the evidence to support various definitions of reduction. Reduction in number of cannabis use days was associated with improvements in functioning across several studies. Reductions in quantity of cannabis used was inconsistently associated with improvements in functioning, though definitions of quantity varied across studies. Different biomarkers may be used depending on the reduction outcome. Biologically-confirmed reductions in frequency of cannabis use days may represent a viable endpoint in clinical trials for cannabis use disorder. Additional research is needed to better quantify reduction in cannabis amounts.

References

Jan 28, 2004·Annual Review of Psychology·Timothy D Wilson, Elizabeth W Dunn
Apr 22, 2006·Therapeutic Drug Monitoring·Frank Musshoff, Burkhard Madea
Oct 13, 2006·Addiction·Brian E LozanoRoger A Roffman
May 8, 2007·Forensic Science International : Synergy·Marilyn A HuestisMichael L Smith
Sep 27, 1974·Science·A Tversky, D Kahneman
May 30, 2008·Annual Review of Clinical Psychology·Saul ShiffmanMichael R Hufford
May 31, 2008·Harm Reduction Journal·Nicole Walden, Mitch Earleywine
Mar 14, 2009·The American Journal on Addictions·Kevin M GrayDouglas K Christie
Dec 2, 2009·Psychological Assessment·Saul Shiffman
May 15, 2010·Journal of Analytical Toxicology·Stefan W ToennesGerold F Kauert
Sep 25, 2010·Drug and Alcohol Dependence·John J MarianiFrances R Levin
Jun 10, 2011·Cyberpsychology, Behavior and Social Networking·Hans-Peter TossmannEvelin Strüber
Oct 1, 2011·Drug and Alcohol Dependence·Melissa M NorbergJan Copeland
Jan 26, 2012·Clinical Chemistry·Dayong LeeMarilyn A Huestis
Jun 1, 2013·International Journal of Nursing Studies·Jason W Beckstead
Aug 21, 2013·Analytical and Bioanalytical Chemistry·Sebastien AnizanMarilyn A Huestis
Aug 29, 2013·Drug Testing and Analysis·Dayong Lee, Marilyn A Huestis
Sep 21, 2013·Clinical Chemistry·Sarah K HimesMarilyn A Huestis
Apr 5, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Lon S Schneider
May 16, 2014·Analytical and Bioanalytical Chemistry·Nathalie A DesrosiersMarilyn A Huestis
Aug 8, 2015·Alcoholism, Clinical and Experimental Research·Katie WitkiewitzHenry R Kranzler
Oct 27, 2015·JAMA Psychiatry·Deborah S HasinBridget F Grant
Mar 31, 2016·Pharmacotherapy·Brian J Sherman, Aimee L McRae-Clark
May 6, 2016·The Cochrane Database of Systematic Reviews·Peter J GatesLinda Gowing
Sep 21, 2016·Drug Testing and Analysis·Madeleine J SwortwoodMarilyn A Huestis
May 1, 2017·The Lancet. Psychiatry·Deborah S HasinUNKNOWN Alcohol Clinical Trials Initiative (ACTIVE) Workgroup
May 23, 2017·Drug and Alcohol Dependence·Cristina Casajuana KögelAntoni Gual
Nov 6, 2017·Drug and Alcohol Dependence·Garrett M FitzmauriceRoger D Weiss
Dec 22, 2017·Forensic Chemistry·Tara M Lovestead, Thomas J Bruno
Feb 6, 2018·Trends in Molecular Medicine·Marilyn A Huestis, Michael L Smith
Mar 28, 2018·The Lancet. Psychiatry·Chandni HindochaRachel L Tomko

❮ Previous
Next ❯

Citations

Mar 30, 2021·Current Addiction Reports·Erin A McClureChandni Hindocha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Medico-legal Journal
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
I Nishioka
Archives of Disease in Childhood
P Robson
The British Journal of Psychiatry : the Journal of Mental Science
C R Joyce
Drug and Therapeutics Bulletin
© 2021 Meta ULC. All rights reserved